| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Corbus Pharmaceuticals Holdings, Inc. | Chief Operating Officer | Common Stock, par value $0.0001 per share | 51,080 | $377,123 | $7.38 | 17 Feb 2026 | Direct |
| Corbus Pharmaceuticals Holdings, Inc. | Chief Operating Officer | Stock options (right to buy) | 85,095 | 14 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | 17 Feb 2026 | 1 | -$6,253 | 4 | Chief Operating Officer | 18 Feb 2026, 16:32 |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | 03 Feb 2026 | 1 | -$19,537 | 4 | Chief Operating Officer | 04 Feb 2026, 16:24 |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | 14 Jan 2026 | 2 | $0 | 4 | Chief Operating Officer | 16 Jan 2026, 16:30 |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | 13 Mar 2025 | 0 | $0 | 3 | Chief Operating Officer | 18 Mar 2025, 16:45 |